Melt Pharmaceuticals
Needham
About Melt Pharmaceuticals
Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures. Its novel and patented, rapidly dissolving sublingual tablet, provides a needle and opioid-free solution for patients and caregivers. Melt Pharmaceuticals was spun out of Harrow Health in January 2019, after successfully completing our Series A financing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $77.3M
- Funding stage: M&A
- Last round: Series B (Apr 2024)
- Website: meltpharma.com
- Phone: +1 615 733 4730
Industries & Categories
Health Care, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/melt-pharmaceuticals-107183 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.